A Prospective, Non-Interventional Cohort Study of Approved Sofosbuvir-based Regimens in Patients in Mexico With Chronic Hepatitis C Virus Infection in Clinical Practice
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Sponsors Gilead Sciences
- 31 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 12 Dec 2017 Planned End Date changed from 1 Jan 2019 to 1 Jun 2018.
- 12 Dec 2017 Planned primary completion date changed from 1 Jan 2019 to 1 Jun 2018.